Market Overview:
The global paroxetine hydrochloride market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as an increase in the prevalence of anxiety disorders and OCD, and rising demand for better-quality drugs. By type, the purity >99% segment is expected to grow at a higher CAGR than other segments during the forecast period. This can be attributed to increasing awareness about better-quality drugs and their benefits among consumers.
Product Definition:
Paroxetine Hydrochloride is a drug used to treat depression, anxiety disorders, and other conditions. It belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). Paroxetine Hydrochloride works by increasing the amount of serotonin in the brain.
Purity:98%-99%:
Purity:98%-99%, it's usage.
The global paroxetine hydrochloride market is expected to witness significant growth over the forecast period owing to increasing demand for the drug as a result of rising incidence of stress-related disorders such as anxiety, insomnia, and restlessness. The growing prevalence of these conditions is anticipated to boost product demand over the coming years.
Purity:>99%:
Purity: 99% is a pharmaceutical drug product which has no major side effects and can be used in almost all types of medicines. It helps to increase the efficiency of medicines by reducing impurities, thus making it suitable for wide range applications such as paroxetine hydrochloride market.
Application Insights:
Paroxetine is used for the treatment of anxiety disorders, such as social anxiety disorder, panic disorder with or without agoraphobia, and generalised anxiety disorder. The drug is also used for the treatment of obsessive-compulsive disorders (OCD), such as Obsessive Compulsive Disorder (OCD) in adults and children. According to a survey conducted by the National Institute of Mental Health, it was estimated that approximately 1 in 5 women and 1 in 10 men suffer from OCD at some point during their life span. However, due to lack of awareness about this disease and its symptoms among general population as well as healthcare professionals; prevalence rate for OCD is relatively low compared to other mental illnesses.
The others segment includes post-traumatic stress disorder (PTSD) and phobias/Panic Disorder With Agoraphobia (PDW).
Regional Analysis:
Asia Pacific was the largest market for paroxetine hydrochloride in 2016, with a revenue share of over 45.0%. The presence of global players and increased R&D spending by the companies are among the key factors contributing to this dominance. In addition, growing awareness about mental health conditions and an increase in disposable income are expected to drive growth during the forecast period.
The Asia Pacific is followed by Europe which accounted for a significant share owing to high demand from countries such as Germany and France along with other Eastern European countries. Latin America is also estimated to witness considerable growth due to increasing healthcare expenditure coupled with rising patient awareness levels regarding treatment options across various mental disorders including anxiety disorder (OCD), major depression disorder (MDD), panic disorder (PD) & agoraphobia).
Growth Factors:
- Increasing prevalence of depression and anxiety disorders
- Growing awareness about the benefits of antidepressants
- Rising demand for better-tolerated antidepressants with fewer side effects
- Availability of generic versions of paroxetine hydrochloride
- Emerging markets offer significant growth potential
Scope Of The Report
Report Attributes
Report Details
Report Title
Paroxetine Hydrochloride Market Research Report
By Type
Purity:98%-99%, Purity:>99%
By Application
OCD Treatment, Anxiety Treatment, Others
By Companies
Sun Pharam, Enal Drugs, Jubilant Pharma, Chemi SPA, GenPharma, Kisch Pharma, Sumitomo Chemical, Azelis Pharma, M.Biotech Limited, Srini Pharmaceuticals Private Limited, Shanghai Everchem, Zhejiang Yongtai Technology, Zhejiang Huahai Pharmaceutial, Zhejiang Haisen Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Paroxetine Hydrochloride Market Report Segments:
The global Paroxetine Hydrochloride market is segmented on the basis of:
Types
Purity:98%-99%, Purity:>99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
OCD Treatment, Anxiety Treatment, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sun Pharam
- Enal Drugs
- Jubilant Pharma
- Chemi SPA
- GenPharma
- Kisch Pharma
- Sumitomo Chemical
- Azelis Pharma
- M.Biotech Limited
- Srini Pharmaceuticals Private Limited
- Shanghai Everchem
- Zhejiang Yongtai Technology
- Zhejiang Huahai Pharmaceutial
- Zhejiang Haisen Pharmaceutical
Highlights of The Paroxetine Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity:98%-99%
- Purity:>99%
- By Application:
- OCD Treatment
- Anxiety Treatment
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Paroxetine Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Paroxetine hydrochloride is an antidepressant medication that is used to treat major depressive disorder (MDD). It works by improving the way the brain processes serotonin, a chemical messenger.
Some of the major companies in the paroxetine hydrochloride market are Sun Pharam, Enal Drugs, Jubilant Pharma, Chemi SPA, GenPharma, Kisch Pharma, Sumitomo Chemical, Azelis Pharma, M.Biotech Limited, Srini Pharmaceuticals Private Limited, Shanghai Everchem, Zhejiang Yongtai Technology, Zhejiang Huahai Pharmaceutial, Zhejiang Haisen Pharmaceutical.
The paroxetine hydrochloride market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Paroxetine Hydrochloride Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Paroxetine Hydrochloride Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Paroxetine Hydrochloride Market - Supply Chain
4.5. Global Paroxetine Hydrochloride Market Forecast
4.5.1. Paroxetine Hydrochloride Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Paroxetine Hydrochloride Market Size (000 Units) and Y-o-Y Growth
4.5.3. Paroxetine Hydrochloride Market Absolute $ Opportunity
5. Global Paroxetine Hydrochloride Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Paroxetine Hydrochloride Market Size and Volume Forecast by Type
5.3.1. Purity:98%-99%
5.3.2. Purity:>99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Paroxetine Hydrochloride Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Paroxetine Hydrochloride Market Size and Volume Forecast by Application
6.3.1. OCD Treatment
6.3.2. Anxiety Treatment
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Paroxetine Hydrochloride Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Paroxetine Hydrochloride Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Paroxetine Hydrochloride Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Paroxetine Hydrochloride Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Paroxetine Hydrochloride Demand Share Forecast, 2019-2026
9. North America Paroxetine Hydrochloride Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Paroxetine Hydrochloride Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Paroxetine Hydrochloride Market Size and Volume Forecast by Application
9.4.1. OCD Treatment
9.4.2. Anxiety Treatment
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Paroxetine Hydrochloride Market Size and Volume Forecast by Type
9.7.1. Purity:98%-99%
9.7.2. Purity:>99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Paroxetine Hydrochloride Demand Share Forecast, 2019-2026
10. Latin America Paroxetine Hydrochloride Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Paroxetine Hydrochloride Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Paroxetine Hydrochloride Market Size and Volume Forecast by Application
10.4.1. OCD Treatment
10.4.2. Anxiety Treatment
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Paroxetine Hydrochloride Market Size and Volume Forecast by Type
10.7.1. Purity:98%-99%
10.7.2. Purity:>99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Paroxetine Hydrochloride Demand Share Forecast, 2019-2026
11. Europe Paroxetine Hydrochloride Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Paroxetine Hydrochloride Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Paroxetine Hydrochloride Market Size and Volume Forecast by Application
11.4.1. OCD Treatment
11.4.2. Anxiety Treatment
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Paroxetine Hydrochloride Market Size and Volume Forecast by Type
11.7.1. Purity:98%-99%
11.7.2. Purity:>99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Paroxetine Hydrochloride Demand Share, 2019-2026
12. Asia Pacific Paroxetine Hydrochloride Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Paroxetine Hydrochloride Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Paroxetine Hydrochloride Market Size and Volume Forecast by Application
12.4.1. OCD Treatment
12.4.2. Anxiety Treatment
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Paroxetine Hydrochloride Market Size and Volume Forecast by Type
12.7.1. Purity:98%-99%
12.7.2. Purity:>99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Paroxetine Hydrochloride Demand Share, 2019-2026
13. Middle East & Africa Paroxetine Hydrochloride Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Paroxetine Hydrochloride Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Paroxetine Hydrochloride Market Size and Volume Forecast by Application
13.4.1. OCD Treatment
13.4.2. Anxiety Treatment
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Paroxetine Hydrochloride Market Size and Volume Forecast by Type
13.7.1. Purity:98%-99%
13.7.2. Purity:>99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Paroxetine Hydrochloride Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Paroxetine Hydrochloride Market: Market Share Analysis
14.2. Paroxetine Hydrochloride Distributors and Customers
14.3. Paroxetine Hydrochloride Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sun Pharam
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Enal Drugs
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Jubilant Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Chemi SPA
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GenPharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Kisch Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sumitomo Chemical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Azelis Pharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. M.Biotech Limited
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Srini Pharmaceuticals Private Limited
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Shanghai Everchem
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Zhejiang Yongtai Technology
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Zhejiang Huahai Pharmaceutial
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Zhejiang Haisen Pharmaceutical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
